Engineered t cells take on deadly brain cancers
NCT ID NCT04099797
First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 3 times
Summary
This early-phase trial tests a new type of immune therapy for people with certain aggressive brain tumors, including DIPG and high-grade glioma. The treatment uses the patient's own T cells, which are modified in the lab to recognize a protein called GD2 on cancer cells and to produce a signal that helps them survive longer. The cells are given first through a vein and then directly into the fluid around the brain. The main goal is to find the safest dose and see if the cells can shrink tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- C7R-GD2.CART cells (a type of modified immune cell)
- What this could lead to
- If it works, this could point toward a new treatment option for aggressive brain tumors like DIPG and high-grade glioma.
- What could go wrong
- This is an early phase 1 trial with only 56 participants, so it is too soon to know if it will be effective. Risks include side effects from the cell infusion and chemotherapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL TERATOID/RHABDOID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas Children's Hospital
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Can the Body's own immune cells beat a recurrent brain tumor?
- Could cutting a wider margin around brain tumors extend survival?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a 7-Week brain tumor treatment beat the standard 10-Week plan?
- Could a parasite drug fight childhood brain tumors?